
| Pair Name | Berbamine, Aspirin | ||
| Phytochemical Name | Berbamine (PubChem CID: 275182 ) | ||
| Anticancer drug Name | Aspirin (PubChem CID: 2244 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Berbamine, Aspirin | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Gene Regulation | Down-regulation | Phosphorylation | CREB1 | hsa1385 |
| Down-regulation | Phosphorylation | ATF1 | hsa466 | |
| Down-regulation | Expression | CIP2A | hsa57650 | |
| Down-regulation | Expression | CCND1 | hsa595 | |
| In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
| Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens (Human) | CVCL_0326 | |
| In Vivo Model | HepG2 cells (4×10⁶ in 125 μL PBS) were subcutaneously injected into 5-week-old BALB/c nude mice. | |||
| Result | These data demonstrate that the regulation of cAMP-PKA-CREB/ATF1 signaling represents a noncanonical function of CPS1. Targeting the PKA-CREB/ATF1 axis may be a strategy to improve the therapeutic effects of aspirin on HCC. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma. Cancers (Basel). 2021 Apr 6;13(7):1738. doi: 10.3390/cancers13071738. | Click |